{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:23:22Z","timestamp":1762341802144},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,9,15]]},"DOI":"10.2169\/internalmedicine.9288-21","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T22:08:28Z","timestamp":1645222108000},"page":"2747-2751","source":"Crossref","is-referenced-by-count":2,"title":["Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor"],"prefix":"10.2169","volume":"61","author":[{"given":"Togo","family":"Sakai","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Ueno","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nyuta","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshibumi","family":"Antoku","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokushi","family":"Koga","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsuchihashi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Steel Memorial Yawata Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Piccini JP, Fauchier L. Rhythm control in atrial fibrillation. Lancet 388: 829-840, 2016.","DOI":"10.1016\/S0140-6736(16)31277-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Briceno DF, Villablanca PA, Lupercio F, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression. J Cardiovasc Electrophysiol 27: 683-693, 2016.","DOI":"10.1111\/jce.12975"},{"key":"3","unstructured":"3. The Japanese Circulation Society. Guidelines for indications and procedural techniques of catheter ablation. Circ J [Internet]. 2012 [cited 2022 Jan 4]. [3-67]. Available from: https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2018\/07\/JCS2018_kurita_nogami.pdf (in Japanese)."},{"key":"4","unstructured":"4. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39: 119-177, 2018."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Baetz BE, Gerstenfeld EP, Kolansky DM, et al. Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia. Pharmacotherapy 30: 952, 2010.","DOI":"10.1592\/phco.30.9.952"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 120: 4160-4167, 2012.","DOI":"10.1182\/blood-2012-07-443051"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 8: 2642-2650, 2010.","DOI":"10.1111\/j.1538-7836.2010.04059.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood 119: 2209-2218, 2012.","DOI":"10.1182\/blood-2011-11-376293"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee GM, Arepally GM. Heparin-induced thrombocytopenia. Hematology Am Soc Hematol Educ Program 2013: 668-674, 2013.","DOI":"10.1182\/asheducation-2013.1.668"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barrio-Lopez MT, Sanchez-Quintana D, Garcia-Martinez J, et al. Epicardial connections involving pulmonary veins: the prevalence, predictors, and implications for ablation outcome. Circ Arrhythm Electrophysiol 13: e007544, 2020.","DOI":"10.1161\/CIRCEP.119.007544"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kang H, Takemoto M, Tayama KI, et al. A case report of atrial fibrillation in a patient with heparin resistance associated with an antithrombin III deficiency successfully treated by radiofrequency catheter ablation using a direct thrombin inhibitor. Eur Heart J Case Rep 3: yty166, 2019.","DOI":"10.1093\/ehjcr\/yty166"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Voskoboinik A, Butcher E, Sandhu A, et al. Direct thrombin inhibitors as an alternative to heparin during catheter ablation: a multicenter experience. JACC Clin Electrophysiol 6: 484-490, 2020.","DOI":"10.1016\/j.jacep.2019.12.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rossig L, Genth-Zotz S, Rau M, et al. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol 148: 214-219, 2011.","DOI":"10.1016\/j.ijcard.2010.02.044"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kaku B, Katsuda S, Taguchi T, et al. A case of acute myocardial infarction with repetitive stent thrombosis during emergent percutaneous coronary intervention. Transient decrease in antithrombin III activity and heparin resistance. Int Heart J 50: 111-119, 2009.","DOI":"10.1536\/ihj.50.111"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gilmore JF, Adams CD, Blum RM, et al. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia. Am J Hematol 90: E143-E145, 2015.","DOI":"10.1002\/ajh.24042"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Grouzi E. Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II. J Blood Med 5: 131-141, 2014.","DOI":"10.2147\/JBM.S38762"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/18\/61_9288-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T03:25:29Z","timestamp":1663385129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/18\/61_9288-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":16,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9288-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"article-number":"9288-21"}}